42 research outputs found
Role of inflammation and oxidative stress in post-menopausal oestrogen-dependent breast cancer
Weight gain and obesity are among the most important risk factors for post-menopausal oestrogen-dependent breast cancer (EDBC). Weight gain is associated with oxidative stress, which in turn promotes breast cancer progression. We carried out a prospective study in 216 consecutive post-menopausal breast cancer patients aiming to examine the correlations between traditional prognostic factors (tumour size, T, nodal, N, grading, G, and metastasis status, M), and body mass index (BMI), leptin, pro-inflammatory cytokines (Interleukin, IL,-6 and tumour necrosis factor-alpha, TNF-α), and oxidative stress (reactive oxygen species, ROS, glutathione peroxidase, GPx, superoxide dismutase, SOD) among patients with oestrogen receptor (ER)+ and ER- breast cancers. Distribution of T, N and M categories did not differ between ER+ and ER- breast cancer patients. ER- patients showed a higher incidence of G3 tumours. Weight, BMI, leptin, IL-6 and ROS were higher in ER+ compared with ER- patients. Among ER+ patients, BMI, leptin, IL-6 and ROS correlated with T and M. Leptin, IL-6 and ROS were positively correlated also with N. Among ER- patients, BMI and leptin did not correlate with any of prognostic parameters, whereas a positive correlation between IL-6, ROS and M was found. Multivariate regression analysis showed that BMI, leptin, IL-6 and ROS were predictive for T, N and M in ER+ patients. Weight gain, inflammation and oxidative stress are involved in EDBC prognosis. Their modulation through antidiabetic, anti-inflammatory and antioxidants drugs combined with endocrine therapy may constitute a targeted approach in post-menopausal EDBC
PD-0481: Local control and cosmetic outcome on 100 early breast cancer treated with exclusive IORT
Rapid rotational foam molding of integral skin polypropylene cellular composites
Rapid Rotational Foam Molding (RRFM) is a novel patent-pending process that was
designed and developed to maximize the synergistic effects resulting from the deliberate
combination of extrusion and rotational foam molding and thereby serve as a time-andenergy
efficient technology for the manufacture of integral-skin rotationally molded
foams of high quality. This thesis presents a thorough study of the scientific and
engineering aspects related to the evolution of the RRFM process and its feasibility. This
innovative processing technology was assessed and verified through a battery of planned
experimental trials conducted utilizing an in-house custom-built industrial-grade lab-scale
experimental setup. The experimental trials involved a variety of polypropylene (PP)-
based foamable formulations with a chemical blowing agent (CBA) that were
compounded and processed by utilizing an extruder and then foamed and injected as a
foamed core, instantly, into the cavity of a suitable non-chilled rotationally molded
hollow shell made of non-foamed pulverized PP grades. The investigated mold shapes
included a cylindrical shaped mold and a rectangular flat shaped mold. The obtained
moldings were examined for the quality of the skin surface, the skin-foam interface, and
the achieved foam morphologies that were characterized in terms of foam density,
average cell size, and average cell density. Optimal processing parameters were
successfully determined for three different PP skin-foam formulation combinations. The
accomplished reduction in processing time and energy consumption by implementing
RRFM were substantial. A variety of processing impediments that hindered the efficiency
of the single-charge conventional rotational foam molding practice were resolved by
implementing RRFM; these include: the foam/skin invasion into the skin/foam layer of
the manufactured article and the premature decomposition of CBA during compounding
or subsequent rotational foam molding processing steps
The Mediterranean fishery management: A call for shifting the current paradigm from duplication to synergy
Independence of science and best available science are fundamental pillars of the UN-FAO code of conduct for responsible fisheries and are also applied to the European Union (EU) Common Fishery Policy (CFP), with the overarching objective being the sustainable exploitation of the fisheries resources. CFP is developed by DG MARE, the department of the European Commission responsible for EU policy on maritime affairs and fisheries, which has the Scientific, Technical and Economic Committee for Fisheries (STECF) as consultant body. In the Mediterranean and Black Sea, the General Fisheries Commission for the Mediterranean (FAO-GFCM), with its own Scientific Advisory Committee on Fisheries (GFCM-SAC), plays a critical role in fisheries governance, having the authority to adopt binding recommendations for fisheries conservation and management. During the last years, advice on the status of the main stocks in the Mediterranean and Black Sea has been provided both by GFCM-SAC and EU-STECF, often without a clear coordination and a lack of shared rules and practices. This has led in the past to: i) duplications of the advice on the status of the stocks thus adding confusion in the management process and, ii) a continuous managers’ interference in the scientific process by DG MARE officials hindering its transparency and independence. Thus, it is imperative that this stalemate is rapidly resolved and that the free role of science in Mediterranean fisheries assessment and management is urgently restored to assure the sustainable exploitation of Mediterranean marine resources in the future.En prens
Autoimmunity in gestational diabetes mellitus in Sardinia: a preliminary case-control report
<p>Abstract</p> <p>Background</p> <p>We previously reported a high prevalence (22.3%) of gestational diabetes mellitus (GDM) in a large group of Sardinian women, in contrast with the prevalence of Type 2 diabetes. Sardinia has an unusual distribution of haplotypes and genotypes, with the highest population frequency of HLA DR3 in the world, and after Finland, the highest prevalence of Type 1 diabetes and Autoimmune-related Diseases. In this study we preliminarily tested the prevalence of serological markers of Type 1 diabetes in a group of Sardinian GDM patients.</p> <p>Methods</p> <p>We determined glutamic decarboxylase antibodies (anti-GAD65), protein tyrosine phosphatase ICA 512 (IA2) antibodies (anti-IA2), and IAA in 62 GDM patients, and in 56 controls with matching age, gestational age and parity.</p> <p>Results</p> <p>We found a high prevalence and very unusual distribution of antibodies in GDM patients (38.8%), the anti-IA2 being the most frequent antibody. Out of all our GDM patients, 38.8% (24 of 62) were positive for at least one antibody. Anti-IA2 was present in 29.0 % (18 out of 62) vs. 7.1% (4 out of 56) in the controls (P < 0.001). IAA was present in 14.5% (9 out of 62) of our GDM patients, and absent in the control subjects (P < 0.001). Anti-GAD65 was also present in GDM patients, with a prevalence of 3.2% (2 out of 62) while it was absent in the control group (P = NS). Pre-gestational weight was significantly lower (57.78 ± 9.8 vs 65.9 ± 17.3 <it>P </it>= 0.04) in auto-antibodies- positive GDM patients.</p> <p>Conclusion</p> <p>These results are in contrast with the very low prevalence of all antibodies reported in Italy. If confirmed, they could indicate that a large proportion of GDM patients in Sardinia have an autoimmune origin, in accordance with the high prevalence of Type 1 diabetes.</p